بدائل البحث:
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
17 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), we decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
17 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), we decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
-
1081
-
1082
-
1083
-
1084
-
1085
-
1086
-
1087
-
1088
-
1089
-
1090
-
1091
-
1092
-
1093
-
1094
-
1095
The Laboratory Animal Flow Diagram.
منشور في 2025"…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …"
-
1096
<sup>1</sup>H NMR spectra for kylo-0603.
منشور في 2025"…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …"
-
1097
<sup>13</sup>C NMR spectra for Kylo-0603.
منشور في 2025"…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …"
-
1098
The structures of T3 and Kylo-0603.
منشور في 2025"…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …"
-
1099
Synthesis process of Kylo-0603.
منشور في 2025"…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …"
-
1100
ESI-HRMS spectra for Kylo-0603.
منشور في 2025"…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …"